Prevention and treatment of thrombosis in cancer and oncohematological patients

Prevention and treatment of thrombosis in cancer and oncohematological patients

The purpose of the review is to highlight the current possibilities for the prevention and treatment of venous thrombotic complications in patients with cancer.The data of 52 scientific sources published in the Russian and foreign press in 1997–2020 are considered.Cancer patients are at high risk of...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. V. Somonova, A. L. Elizarova, T. V. Davydova
Format:	Article
Language:	Russian
Published:	ABV-press 2021-11-01
Series:	Онкогематология
Subjects:	cancer patient thrombotic complication low molecular weight heparin direct oral anticoagulant
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/503
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THROMBOPHILIA, THROMBOSIS AND ANTITHROMBOTIC THERAPY IN CANCER PATIENTS
by: A. V. Vorobev, et al.
Published: (2016-06-01)

Osteoporosis and antithrombotic therapy
by: N. V. Brailova, et al.
Published: (2021-06-01)

Sinovenous Thrombosis: Anticoagulation Therapy
by: J Gordon Millichap
Published: (1998-12-01)

Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue
by: O. D. Ostroumova, et al.
Published: (2020-07-01)

Pharmacokinetics of low molecular weight heparins in thrombosis, complicate the treatment of children with cancer
by: V. V. Dmitriev, et al.
Published: (2021-04-01)

Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2023-10-01)

ANTITHROMBOTIC THERAPY IN CANCER PATIENTS
by: A. V. Vorobev, et al.
Published: (2016-06-01)

Mitral valve nonbacterial thrombotic endocarditis: a rare multi-surgery-tolerant survivor of Trousseau’s syndrome
by: Yoshiharu Soga, et al.
Published: (2018-08-01)

Anticoagulation Management Post Pulmonary Embolism
by: Joseph J. Naoum
Published: (2024-05-01)

Multifaceted role of heparin in oncology: from anticoagulation to anticancer mechanisms and clinical implications
by: Niranjan Koirala, et al.
Published: (2025-02-01)

Expanding the possibilities of treatment and prevention of venous thromboembolic complications in cancer patients. The role of oral anticoagulants
by: R. A. Bredikhin, et al.
Published: (2022-10-01)

Anticoagulants: dose control methods and inhibitors
by: V. O. Bitsadze, et al.
Published: (2022-05-01)

The role of anticoagulants in the treatment of community-acquired pneumonia in patients combined with coronavirus infection
by: I. M. Fushtei, et al.
Published: (2025-02-01)

High-dose postpartum thromboprophylaxis in women at high risk of pregnancy-related venous thromboembolism: a single-center prospective cohort study
by: Sean C.S. Rivrud, et al.
Published: (2025-03-01)

International normalized ratio measurement during perioperative anticoagulation bridging with low-molecular-weight heparin in patients undergoing heart valve replacement surgery
by: Liza Rijvers, et al.
Published: (2024-11-01)

Influence of low molecular weight heparin on cancer patients’ survival
by: V. V. Ptushkin
Published: (2014-07-01)

PLACENTAL INSUFFICIENCY IN COMPLICATED PREGNANCY AND POSSIBILITY OF TREATMENT WITH DIPYRIDAMOLE
by: A. D. Makatsariya, et al.
Published: (2017-03-01)

Innovative approaches to assessing risk factors, diagnostics and treatment of neonatal thrombosis
by: A. D. Makatsariya, et al.
Published: (2024-07-01)

Anticoagulants in the treatment of superficial vein thrombosis of lower limbs: possibilities and limitations
by: I. S. Yavelov, et al.
Published: (2022-01-01)

Venous thrombosis in children, adolescents and young adults with acute lymphoblastic leukemia receiving chemotherapy in the Republic of Belarus
by: V. V. Dmitriev, et al.
Published: (2019-07-01)

OPTIONS FOR USE OF APPROPRIATE ANTICOAGULANT THERAPY IN PATIENTS WITH THERMAL INJURY WITH A HIGH RISK OF THROMBOEMBOLIC COMPLICATIONS DEVELOPMENT ASSOCIATED WITH RECURRENT INTESTINAL BLEEDING
by: V. S. Borisov, et al.
Published: (2016-02-01)

Venous thrombosis associated with pancreatic cancer
by: Vlad Buică, et al.
Published: (2024-04-01)

RARE THROMBOSIS LOCALIZATION IN A CANCER PATIENT WITH COMBINED THROMBOPHILIA: A CLINICAL CASE
by: A. V. Vorobiev, et al.
Published: (2017-12-01)

Expanding the Role of Heparin Derivatives in Oncology: From Anticoagulation to Antitumor Activity
by: Jasmine Holail, et al.
Published: (2025-03-01)

Advisory Board conclusion following the discussion "Controversial issues of low molecular weight heparins use in obstetrics"
by: article Editorial
Published: (2021-09-01)

Low-molecular-weight heparin-induced thrombocytopenia with multisite embolism: successful management with argatroban and dabigatran – a case report and literature review
by: Huixin Zhao, et al.
Published: (2025-07-01)

Approaches for the prevention and treatment of venous thromboembolism in a patient with anaplastic astrocytoma: a case report
by: M. G. Pavlova, et al.
Published: (2021-04-01)

ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?
by: A. L. Komarov, et al.
Published: (2016-01-01)

CLOTTING PREVENTION IN RENAL REPLACEMENT THERAPY: CLASSICAL APPROACHES AND NEW OPPORTUNITIES
by: A. G. Strokov, et al.
Published: (2010-06-01)

Efficacy and safety of low-molecular-weight-heparin plus citrate in nephrotic syndrome during continuous kidney replacement therapy: retrospective study
by: Di Wang, et al.
Published: (2025-02-01)

Strategies for anticoagulation in patients with thrombocytopenia and cancer-associated thrombosis (START): design and rationale of the START pilot randomized controlled trial
by: Tzu–Fei Wang, et al.
Published: (2025-05-01)

Impact of anticoagulation therapy on short-term and long-term prognosis of patients with acute Q-wave myocardial infarction after thrombolytic therapy
by: S. M. Kyselov
Published: (2018-07-01)

Application of anti-coagulation of citric acid in continuous renal replacement therapy for patients with lactic acidosis
by: TIAN Li, et al.
Published: (2019-01-01)

Comparative efficacy of venous thromboembolism prophylaxis in patients with blunt trauma: Direct thrombin inhibitors vs low-molecular-weight heparin
by: Jen-Fu Huang, et al.
Published: (2025-05-01)

Tinzaparin for the Management of Cancer Associated Thrombosis in Patients with Cancer: a Budget Impact Analysis from the Italian Healthcare System Perspective
by: Lorenzo Giovanni Mantovani, et al.
Published: (2025-06-01)

Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital
by: A. S. Kolbin, et al.
Published: (2015-03-01)

Corrigendum to «Innovative approaches to assessing risk factors, diagnostics and treatment of neonatal thrombosis» (https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.530)
by: A. D. Makatsariya, et al.
Published: (2024-11-01)

Management of Postpartum Deep Vein Thrombosis with Inferior Vena Cava Filter Placement: A Case Report
by: Vidhi Jain, et al.
Published: (2025-04-01)

Conservative short-term treatment of non-cirrhotic non-malignant portal vein thrombosis
by: Bošković-Sekulić Jelena, et al.
Published: (2023-01-01)

Efficacy and Safety of the Low-molecular Heparin in Treatment and Prevention of the Acute Coronary Syndrome
by: Katerenchuk I., et al.
Published: (2013-03-01)